Global Acrochordon Treatment Market – Industry Trends and Forecast to 2030

Acrochordon Treatment Market Analysis and Size

The incidence of acrochordons, or skin tags, can vary among different populations and age groups. Skin tags are relatively common, and their occurrence tends to increase with age. While exact incidence rates are challenging to determine, studies have reported varying prevalence rates ranging from 25% to 59% in the general population.

Data Bridge Market Research analyses that the global acrochordon treatment market which was USD 2,152.80 million in 2022, is expected to reach USD 3,303.87 million by 2030, and is expected to undergo a CAGR of 5.50% during the forecast period of 2023 to 2030. “Surgical Excision” dominates the treatment segment of the global acrochordon treatment market owing to the growing demand for better surgical methods for treatment. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Acrochordon Treatment Market Scope and Segmentation

Market Definition

Acrochordon are also known as skin tags and defined as benign, non-cancerous, tumors of the skin. They are extremely common and affect half of the population. The incidence of skin tags increase with the age. Diabetes, obesity, human papillomavirus and pregnancy are the risk factors of this condition. They are characterised by the small, flesh-coloured skin growths that are mostly found in the skin folds such as arm pit, groin or neck.

Global Acrochordon Treatment Market Dynamics

Drivers

• Rising Chronic Diseases

The market for acrochordon treatments is anticipated to grow significantly over the forecast period due to a number of key factors, including the rising prevalence of chronic diseases. The growth in the prevalence of acrochordon, expanding rate of lifestyle ailments such as diabetes, high blood pressure, and obesity.

• Increasing Awareness about Skin Care

The segment is growing significantly as more women incorporate self-care products into their daily routines to boost their self-esteem and appearance. In recent years, the significance of selfcare has inspired women to actively create relaxing self-care experiences through at-home skincare routines. The demand for such products with active ingredients that have nourishing and healing properties is being driven by this trend. The market for men's skincare is expanding as a result of rising disposable income, celebrity endorsements, and increased product launches among men who are becoming more conscious of their personal hygiene and body care. Men's preferences for skincare products are expanding beyond those for traditional grooming.

Opportunities

• Research and Development Proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the skin care and treatment will further create lucrative market growth opportunities. Research and development proficiencies being conducted to provide best of the medications to curb the acrochordon is also bolstering the market growth rate.

• Demand for Non-Surgical Procedures

The growing understanding of the need for skin care and treatment products to shield your skin from factors like cancer and allergies. It is the main driver of the market expansion for skin treatment procedures. The use of natural and non-surgical products is growing in popularity as cases of skin treatments for conditions like allergies, rashes, and other conditions are on the rise. People are becoming more and more interested in non-surgical products and treatment methods for acrochordon treatment. This has been reflected in new product launches and treatment procedures as well.

Restraint/Challenge

• High Cost and Lack of Favorable Treatment

The high cost of surgical treatment and recurrence of skin tags after the treatment are the factors that will hinder the market growth and will further challenge the acrochordon treatment. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, heavy custom duty imposed on the medical devices and treatment accessories, and lack of suitable infrastructure in low-income and middle-income countries are projected to challenge the market in the forecast period of 2023-2030.

This global acrochordon treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global acrochordon treatment market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.

Recent Developments

• In January 2020, Compound W launched a complete wart kit as an over-the-counter (OTC) treatment solution which includes a wart removal solution containing salicylic acid, as well as applicators and bandages for targeted application and protection
• In September 2020, Dr. Scholl's Freeze Away wart remover was launched as an OTC product based on a freezing technology called cryotherapy to remove warts. It has a precision applicator and is designed for home use.

Global Acrochordon Treatment Market Scope

The global acrochordon treatment market is segmented on the basis of treatment, diagnosis, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Over-the-counter (OTC) solution
• Vitamin E
• Cryotherapy
• Ligation
• Electrosurgery
• Surgical excision
• Others

 Diagnosis

• Biopsy
• Others

End Users

• Clinic
• Hospital
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Acrochordon Treatment Market Regional Analysis/Insights

The global acrochordon treatment market is analysed and market size insights and trends are provided by country, treatment, dignose, end-users and distribution channel as referenced above.

The countries covered in the global acrochordon treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the global acrochordon treatment market because of the strong base of healthcare facilities, the strong presence of major players in the market, the extraordinary healthcare infrastructure, and the large pool of people having acrochordons like moles, warts and skin tags.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote healthcare, the rising health awareness among the people and growing demand for advanced medical technology for skin care, the large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global acrochordon treatment market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the acrochordon treatment market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the global  acrochordon market.

Competitive Landscape and Global Acrochordon Treatment Market Share Analysis

The global acrochordon treatment market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the global acrochordon treatment market.

Some of the major players operating in the global acrochordon treatment market are:

• Quantum Cryogenics (U.K)
• Pacira BioSciences, Inc. (U.S)
• ATRICURE, INC. (U.S)
• BTG International Inc. (U.S)
• METRUM CRYOFLEX Sp. z o.o. (Poland)
• Brymill Cryogenic Systems (U.S)
• Kriosystem-Care Sp. z o.o. (Poland)
• US CRYOTHERAPY (U.S)
• CryoConcepts LP. (U.S)
• Erbe Medical India Pvt Ltd. (India)
• Zimmer MedizinSysteme GmbH  (Germany)
• Medtronic (Ireland)
• Cortex Technology (Denmark)
• CooperSurgical, Inc. (U.S)
• Hologic, Inc. (U.S)
• PHYSIOMED AG (Germany)
• Cryomed s.r.o. Cryosaunas & Cryotherapy machines (Slovakia)
• CSA Medical (U.S)
• BOWA-electronic GmbH & Co. KG (Germany)
• Prima Medical (Germany)
• XCELLANCE Medical Technologies (India)
• ATMOS MedizinTechnik GmbH & Co. KG (Germany)
• Johnson & Johnson Private Limited (U.S)
• Smith+Nephew (U.K)
• Symmetry Surgical Inc. (U.S)

SKU-66327